Lurasidone uses and dosages in Spain: RETROLUR, a real-world retrospective analysis using artificial intelligence.

Journal: Frontiers in psychiatry
Published Date: Feb 5, 2025

Abstract

INTRODUCTION: Lurasidone is used for schizophrenia and bipolar depression in many countries, yet there is a lack of existing literature about its use, efficacy, and safety in real life. We aimed to characterize lurasidone-treated patients by analyzing unstructured information in electronic health records (EHRs).

Authors

  • Fernando Mora
    Department of Psychiatry and Mental Health, Hospital Universitario Infanta Leonor, Madrid, Spain.
  • Carlos Gómez Sánchez-Lafuente
    Department of Mental Health, Hospital Regional Universitario de Málaga, Andalucía, Spain.
  • Mariano De Iceta
    Hospital Universitario Infanta Sofía, S.S.Reyes, Madrid, Spain.
  • Carolina Roset
    Department of Psychiatry, Hospital Universitario Son Espases, Islas Baleares, Spain.
  • Antonio Cárdenas
    Medical Department, Angelini Pharma España SLU, Barcelona, Spain.
  • Daniel Pérez
    Medical Department, Angelini Pharma España SLU, Barcelona, Spain.
  • Elena Álvarez-Barón
    Global Medical Department, Angelini Pharma S.p.A., Rome, Italy.
  • Irene Gabarda-Inat
    Global Medical Department, Angelini Pharma S.p.A., Rome, Italy.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals